Aroa Biosurgery Limited (ASX:ARX)

Aroa Biosurgery Revenue

In the fiscal year ending March 31, 2026, Aroa Biosurgery had annual revenue of 103.85M NZD with 22.62% growth. Aroa Biosurgery had revenue of 58.99M in the half year ending March 31, 2026, with 58.61% growth.

• Revenue: 103.85M NZD
• Revenue Growth: +22.62%
• P/S Ratio: 2.58
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 223.11M AUD

Revenue Chart

* This company reports financials in NZD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	103.85M	19.16M	22.62%
Mar 31, 2025	84.70M	15.63M	22.63%
Mar 31, 2024	69.07M	5.71M	9.01%
Mar 31, 2023	63.36M	23.68M	59.68%
Mar 31, 2022	39.68M	17.34M	77.60%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 6, 2026

Data Sources Report a data error